Axcelis Technologies (ACLS)
(Delayed Data from NSDQ)
$97.63 USD
+0.07 (0.07%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $97.77 +0.14 (0.14%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$97.63 USD
+0.07 (0.07%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $97.77 +0.14 (0.14%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth A Momentum B VGM
Zacks News
Axcelis Stock Plunges 16% YTD: Should You Buy, Hold or Sell?
by Vaishali Doshi
ACLS' performance is bearing the brunt of softness in the memory market. It notes that demand may moderate in the General Mature in the second half of 2024.
New Strong Sell Stocks for August 29th
by Zacks Equity Research
BLMN, ACLS and AIQUY have been added to the Zacks Rank #5 (Strong Sell) List on August 29, 2024.
Implied Volatility Surging for Axcelis (ACLS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Axcelis (ACLS) stock based on the movements in the options market lately.
New Strong Sell Stocks for August 13th
by Zacks Equity Research
ADM, ACLS and CVS have been added to the Zacks Rank #5 (Strong Sell) List on August 13, 2024.
Axcelis' (ACLS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Axcelis (ACLS) performance gains from demand for ion implantation systems particularly in the silicon carbide space
Axcelis Technologies (ACLS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Axcelis (ACLS) delivered earnings and revenue surprises of 11.51% and 1.63%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors to Note Ahead of Axcelis' (ACLS) Q2 Earnings Release
by Zacks Equity Research
Axcelis' (ACLS) second-quarter performance is likely to have benefited from increasing demand for the Purion suite of products.
Axcelis Technologies (ACLS) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Axcelis (ACLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Does Axcelis (ACLS) Have the Potential to Rally 28.41% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.4% in Axcelis (ACLS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Roper (ROP) Gears Up to Post Q2 Earnings: Is a Beat in Store?
by Zacks Equity Research
Roper's (ROP) second-quarter earnings are expected to benefit from the robust performance of the Application Software, Network Software and Tech-enabled Products segments.
How to Boost Your Portfolio with Top Computer and Technology Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
How to Find Strong Computer and Technology Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Implied Volatility Surging for Axcelis Technologies (ACLS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Axcelis Technologies (ACLS) stock based on the movements in the options market lately.
Will Axcelis (ACLS) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Axcelis (ACLS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Axcelis Technologies (ACLS) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
Axcelis (ACLS) Sets Up Service Offices for Customers in Japan
by Zacks Equity Research
Axcelis (ACLS) has noted that its service centers are located near the clients, which will facilitate localized support resources for its Purion ion implant equipment which is in production.
Here's Why Axcelis Technologies (ACLS) Fell More Than Broader Market
by Zacks Equity Research
Axcelis Technologies (ACLS) closed the most recent trading day at $138.73, moving -1.72% from the previous trading session.
Axcelis Technologies, Inc. (ACLS) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Zacks.com users have recently been watching Axcelis (ACLS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Implied Volatility Surging for Axcelis Technologies (ACLS) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Axcelis Technologies (ACLS) stock based on the movements in the options market lately.
Is Axcelis (ACLS) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), Axcelis (ACLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Axcelis (ACLS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Axcelis (ACLS) delivers healthy Q1 performance driven by momentum in the implant-intensive power device segment, especially silicon carbide and solid shipments to China.
Here's How Axcelis' (ACLS) is Placed Just Ahead of Q1 Earnings
by Zacks Equity Research
Axcelis' (ACLS) first-quarter performance is likely to have benefited from its leading position in the expanding power device market.
Axcelis Technologies (ACLS) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Axcelis Technologies (ACLS) closed at $97.24 in the latest trading session, marking a +1.95% move from the prior day.
Axcelis Technologies (ACLS) Advances But Underperforms Market: Key Facts
by Zacks Equity Research
Axcelis Technologies (ACLS) closed the most recent trading day at $95.38, moving +0.62% from the previous trading session.
Axcelis Technologies (ACLS) Stock Moves -0.27%: What You Should Know
by Zacks Equity Research
Axcelis Technologies (ACLS) reachead $104.33 at the closing of the latest trading day, reflecting a -0.27% change compared to its last close.